{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:56:04Z","timestamp":1788173764283,"version":"build-2803163510"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.idc.2018.04.006","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T06:18:57Z","timestamp":1535005137000},"page":"687-701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Mold Infections in Solid Organ Transplant Recipients"],"prefix":"10.1016","volume":"32","author":[{"given":"Tracy L.","family":"Lemonovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idc.2018.04.006_bib1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1186\/s12879-016-2023-z","article-title":"Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study","volume":"16","author":"Kontoyiannis","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2018.04.006_bib2","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.ajic.2010.06.009","article-title":"The economic costs to United States hospitals of invasive fungal infections in transplant patients","volume":"39","author":"Menzin","year":"2011","journal-title":"Am J Infect Control"},{"issue":"19","key":"10.1016\/j.idc.2018.04.006_bib3","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2146\/ajhp080325","article-title":"Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients","volume":"66","author":"Menzin","year":"2009","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"10.1016\/j.idc.2018.04.006_bib4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2018.04.006_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3062.2010.00492.x","article-title":"Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients","volume":"12","author":"Neofytos","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.idc.2018.04.006_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/ajt.12118","article-title":"Emerging fungal infections in solid organ transplantation","volume":"13","author":"Huprikar","year":"2013","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.idc.2018.04.006_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.idc.2013.02.004","article-title":"Emerging fungal infections in solid organ transplant recipients","volume":"27","author":"Shoham","year":"2013","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.idc.2018.04.006_bib8","first-page":"821969","article-title":"Invasive mold infections in solid organ transplant recipients","volume":"2014","author":"Crabol","year":"2014","journal-title":"Scientifica (Cairo)"},{"issue":"3","key":"10.1016\/j.idc.2018.04.006_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/tid.12060","article-title":"Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience","volume":"15","author":"Neofytos","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.idc.2018.04.006_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ajt.12115","article-title":"Aspergillosis in solid organ transplantation","volume":"13","author":"Singh","year":"2013","journal-title":"Am J Transpl"},{"issue":"5","key":"10.1016\/j.idc.2018.04.006_bib11","first-page":"453","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J\u00a0Infect"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2018.04.006_bib12","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1080\/13693780400020113","article-title":"Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program","volume":"43","author":"Morgan","year":"2005","journal-title":"Med Mycol"},{"issue":"5","key":"10.1016\/j.idc.2018.04.006_bib13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/00007890-199709150-00009","article-title":"Invasive aspergillosis in liver transplant recipients in the 1990s","volume":"64","author":"Singh","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.idc.2018.04.006_bib14","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2018.04.006_bib15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.04.006_bib16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1600-6143.2004.00415.x","article-title":"Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients","volume":"4","author":"Husain","year":"2004","journal-title":"Am J Transpl"},{"key":"10.1016\/j.idc.2018.04.006_bib17","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2018.04.006_bib18","doi-asserted-by":"crossref","first-page":"562.e1-8","DOI":"10.1016\/j.cmi.2016.01.027","article-title":"Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patients","volume":"22","author":"Imbert","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2018.04.006_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.bmt.1704793","article-title":"What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience","volume":"35","author":"Simoneau","year":"2005","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.idc.2018.04.006_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.idc.2018.04.006_bib21","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other \ufb01lamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2018.04.006_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.tp.0000202421.94822.f7","article-title":"Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study","volume":"81","author":"Singh","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.idc.2018.04.006_bib23","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2006.01548.x","article-title":"Voriconazole prophylaxis in lung transplant recipients","volume":"6","author":"Husain","year":"2006","journal-title":"Am J Transpl"},{"key":"10.1016\/j.idc.2018.04.006_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1378\/chest.104.3.681","article-title":"Infection in the transplanted and native lung after single lung transplantation","volume":"104","author":"Horvath","year":"1993","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.idc.2018.04.006_bib25","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3201\/eid1710.110087","article-title":"Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001\u20132006","volume":"17","author":"Park","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2018.04.006_bib26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/myc.12222","volume":"57","author":"Abidi","year":"2014","journal-title":"Mycoses"},{"issue":"6","key":"10.1016\/j.idc.2018.04.006_bib27","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome","volume":"200","author":"Singh","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2018.04.006_bib28","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/j.1600-6143.2006.01496.x","article-title":"Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature","volume":"6","author":"Almyroudis","year":"2006","journal-title":"Am J Transpl"},{"issue":"9","key":"10.1016\/j.idc.2018.04.006_bib29","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/j.1600-6143.2009.02754.x","article-title":"Pulmonary zygomycosis in solid organ transplant recipients in the current era","volume":"9","author":"Sun","year":"2009","journal-title":"Am J Transpl"},{"issue":"1","key":"10.1016\/j.idc.2018.04.006_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/TP.0b013e3181dde8fc","article-title":"Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients","volume":"90","author":"Sun","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.idc.2018.04.006_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12879-017-2381-1","article-title":"Mucormycosis in renal transplant recipients: review of 174 reported cases","volume":"17","author":"Song","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2018.04.006_bib32","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JCM.01185-16","article-title":"Discrimination of aspergillosis, mucormycosis, fusariosis, and scedosporiosis in formalin-fixed paraffin-embedded tissue specimens by use of multiple real-time quantitative PCR assays","volume":"54","author":"Salehi","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"issue":"10","key":"10.1016\/j.idc.2018.04.006_bib33","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1093\/cid\/cit094","article-title":"Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients","volume":"56","author":"Millon","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2018.04.006_bib34","doi-asserted-by":"crossref","first-page":"810.e1-e8","DOI":"10.1016\/j.cmi.2015.12.006","article-title":"Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)","volume":"22","author":"Millon","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 3","key":"10.1016\/j.idc.2018.04.006_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.idc.2018.04.006_bib36","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2018.04.006_bib37","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2018.04.006_bib38","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2018.04.006_bib39","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/AAC.49.2.830-832.2005","article-title":"Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice","volume":"49","author":"Spellberg","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2018.04.006_bib40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/jac\/dkw433","article-title":"Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis","volume":"72","author":"Gebremariam","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.idc.2018.04.006_bib41","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1128\/AAC.03261-14","article-title":"In\u00a0vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds","volume":"58","author":"Katragkou","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idc.2018.04.006_bib42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/myc.12524","article-title":"Utilization of posaconazole oral suspension or delayed-released tablet salvage treatment for invasive fungal infection","volume":"59","author":"Kim","year":"2016","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.idc.2018.04.006_bib43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/1040841X.2012.711741","article-title":"Mucormycosis treated with posaconazole: review of 96 case reports","volume":"39","author":"Vehreschild","year":"2013","journal-title":"Crit Rev Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2018.04.006_bib44","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/TP.0b013e3181837585","article-title":"Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant","volume":"86","author":"Alexander","year":"2008","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.idc.2018.04.006_bib45","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/cid\/civ571","article-title":"Isavuconazole: a new broad-spectrum triazole antifungal agent","volume":"61","author":"Miceli","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2018.04.006_bib46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/IDR.S102207","article-title":"Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations","volume":"9","author":"Natesan","year":"2016","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.idc.2018.04.006_bib47","first-page":"1925070","article-title":"Successful treatment of recurrent pulmonary mucormycosis in a renal transplant patient: a case report and literature review","volume":"2017","author":"Martin","year":"2017","journal-title":"Case Rep Transplant"},{"issue":"6","key":"10.1016\/j.idc.2018.04.006_bib48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/MD.0000000000000008","article-title":"Fusarium infection: report of 26 cases and review of 97 cases from the literature","volume":"92","author":"Muhammed","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.idc.2018.04.006_bib49","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.transproceed.2010.01.004","article-title":"Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report","volume":"42","author":"Halpern","year":"2010","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.idc.2018.04.006_bib50","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/319753","article-title":"Fusarium infection after solid-organ transplantation","volume":"32","author":"Sampathkumar","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2018.04.006_bib51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MD.0b013e318207612d","article-title":"Fusarium infection in lung transplant patients: report of 6 cases and review of the literature","volume":"90","author":"Carneiro","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.idc.2018.04.006_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00001432-200004000-00005","article-title":"Fusarium infections of the skin","volume":"13","author":"Gupta","year":"2000","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2018.04.006_bib53","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00014-07","article-title":"Fusarium infections in immunocompromised patients","volume":"20","author":"Nucci","year":"2007","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2018.04.006_bib54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1470-9465.2004.00845.x","article-title":"Human fusariosis","volume":"10","author":"Dignani","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 3","key":"10.1016\/j.idc.2018.04.006_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12465","article-title":"ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others","volume":"20","author":"Tortorano","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.idc.2018.04.006_bib56","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.02456-15","article-title":"International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for fusarium species identified by molecular methods for the CLSI broth microdilution method","volume":"60","author":"Espinel-Ingroff","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2018.04.006_bib57","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1128\/JCM.05946-11","article-title":"Cross-reactivity of Fusarium spp. in the Aspergillus galactomannan enzyme-linked immunosorbent assay","volume":"50","author":"Tortorano","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2018.04.006_bib58","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/myc.12212","article-title":"Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(\u00ae) registry","volume":"57","author":"Horn","year":"2014","journal-title":"Mycoses"},{"issue":"10","key":"10.1016\/j.idc.2018.04.006_bib59","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1086\/503425","article-title":"Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions","volume":"42","author":"Raad","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2018.04.006_bib60","first-page":"872","article-title":"Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: a case report and literature review","volume":"49","author":"Liu","year":"2011","journal-title":"Med Mycol"},{"issue":"3","key":"10.1016\/j.idc.2018.04.006_bib61","doi-asserted-by":"crossref","first-page":"ofv099","DOI":"10.1093\/ofid\/ofv099","article-title":"Invasive fusariosis in the voriconazole era: single-center 13-year experience","volume":"2","author":"Stempel","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2018.04.006_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13225-014-0295-4","article-title":"Proposed nomenclature for Pseudallescheria, Scedosporium and related genera","volume":"1","author":"Lackner","year":"2014","journal-title":"Fungal Divers"},{"issue":"1","key":"10.1016\/j.idc.2018.04.006_bib63","doi-asserted-by":"crossref","first-page":"12792","DOI":"10.1111\/tid.12792","article-title":"A\u00a0cluster of scedosporiosis in lung transplant candidates and recipients: the Zurich experience and review of the literature","volume":"20","author":"Abela","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2018.04.006_bib64","doi-asserted-by":"crossref","first-page":"12738","DOI":"10.1111\/tid.12738","article-title":"Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: a single-center 15-year experience","volume":"19","author":"Parize","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2018.04.006_bib65","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/tid.12244","article-title":"Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients","volume":"16","author":"Johnson","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2018.04.006_bib66","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/AAC.01388-07","article-title":"Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients","volume":"52","author":"Troke","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2018.04.006_bib67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00005792-200209000-00001","article-title":"Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature","volume":"81","author":"Castiglioni","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.idc.2018.04.006_bib68","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/AAC.05910-11","article-title":"Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species","volume":"56","author":"Lackner","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2018.04.006_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/426445","article-title":"Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome","volume":"40","author":"Husain","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2018.04.006_bib70","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s15010-011-0108-6","article-title":"The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis","volume":"39","author":"Schwartz","year":"2011","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.idc.2018.04.006_bib71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/CMR.00039-07","article-title":"Infections caused by Scedosporium spp","volume":"21","author":"Cortez","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.idc.2018.04.006_bib72","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/AAC.01477-08","article-title":"Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans","volume":"53","author":"Rodr\u00edguez","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2018.04.006_bib73","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/tid.12197","article-title":"Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment","volume":"16","author":"Schieffelin","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2018.04.006_bib74","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/mmy\/myv018","article-title":"Phaeohyphomycosis in transplant recipients: results from the Transplant Associated Infection Surveillance Network (TRANSNET)","volume":"53","author":"McCarty","year":"2015","journal-title":"Med Mycol"},{"issue":"5","key":"10.1016\/j.idc.2018.04.006_bib75","doi-asserted-by":"crossref","first-page":"333.e9-e14","DOI":"10.1016\/j.cmi.2016.12.024","article-title":"Melanized fungal infections in kidney transplant recipients: contributions to optimize clinical management","volume":"23","author":"Santos","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 3","key":"10.1016\/j.idc.2018.04.006_bib76","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/1469-0691.12515","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi","volume":"20","author":"Chowdhary","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2018.04.006_bib77","series-title":"Transplant infections","first-page":"719","article-title":"Mold infections in solid organ transplant recipients","author":"Mu\u00f1oz","year":"2016"},{"issue":"6","key":"10.1016\/j.idc.2018.04.006_bib78","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.1111\/tid.12020","article-title":"Simultaneous cutaneous infection due to Paecilomyces lilacinus and Alternaria in a heart transplant patient","volume":"14","author":"Lavergne","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2018.04.006_bib79","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1399-3062.2010.00507.x","article-title":"Synchronous infection with Mycobacterium chelonae and Paecilomyces in a heart transplant patient","volume":"13","author":"Kim","year":"2011","journal-title":"Transpl Infect Dis"},{"issue":"3\u20134","key":"10.1016\/j.idc.2018.04.006_bib80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11046-014-9854-1","article-title":"Successful treatment of Paecilomyces variotii peritonitis in a liver transplant patient","volume":"179","author":"Polat","year":"2015","journal-title":"Mycopathologia"},{"issue":"10","key":"10.1016\/j.idc.2018.04.006_bib81","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S1053-2498(02)00404-7","article-title":"Delayed sternotomy wound infection due to Paecilomyces variotii in a lung transplant recipient","volume":"21","author":"Lee","year":"2002","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.idc.2018.04.006_bib82","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/tid.12506","article-title":"Successful eradication of invasive Scopulariopsis brumptii in a liver transplant recipient","volume":"18","author":"Pate","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2018.04.006_bib83","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1086\/344270","article-title":"Invasive infections due to Trichoderma species: report of 2 cases, findings of in\u00a0vitro susceptibility testing, and review of the literature","volume":"35","author":"Chouaki","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2018.04.006_bib84","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jaad.2006.08.001","article-title":"Acremonium mycetoma in a heart transplant recipient","volume":"55","author":"Geyer","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.idc.2018.04.006_bib85","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/phar.1233","article-title":"The evolving role of antifungal susceptibility testing","volume":"33","author":"Eschenauer","year":"2013","journal-title":"Pharmacotherapy"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552018300412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552018300412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T04:20:04Z","timestamp":1604809204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552018300412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0891552018300412"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2018.04.006","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mold Infections in Solid Organ Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2018.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}